Related Experiment Video
Updated: Mar 7, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
Liver Function Tests in Tuberculoid Leprosy
Tuberculoid leprosy patients showed no significant liver function test alterations. Minimal, focal liver changes in leprosy were too subtle for standard tests to detect.
Area of Science:
- Hepatology
- Infectious Diseases
- Immunology
Background:
- Leprosy, particularly tuberculoid leprosy, can affect various organs.
- Previous studies indicated significant liver involvement in 85% of these patients.
- Understanding subclinical liver impact is crucial for comprehensive patient management.
Purpose of the Study:
- To evaluate liver function in patients with untreated tuberculoid leprosy.
- To correlate clinical observations of liver involvement with biochemical liver function tests.
- To determine if standard liver function tests can detect minimal hepatic changes in leprosy.
Main Methods:
- Study included 24 patients with untreated tuberculoid leprosy.
- Five healthy individuals served as controls.
- Standard liver function tests were performed, including prothrombin time, serum bilirubin, zinc sulphate turbidity, serum proteins, and serum transaminases.
Main Results:
- No statistically significant alterations were observed in the liver function tests of leprosy patients compared to controls.
- Despite prior histological evidence of liver involvement, biochemical tests did not reflect these changes.
- This suggests that minimal and focal hepatic changes may not be detectable by conventional liver function assays.
Conclusions:
- Standard liver function tests are not sensitive enough to detect minimal, focal liver involvement in tuberculoid leprosy.
- Further research may be needed to identify more sensitive biomarkers for subclinical liver disease in leprosy patients.
- Clinical management should consider potential subclinical organ involvement even with normal biochemical test results.
More Related Videos
08:10A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux
Published on: September 14, 2011
10:32Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...